Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

GlycoMimetics Total Assets 2012-2023 | GLYC

GlycoMimetics total assets from 2012 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
GlycoMimetics Annual Total Assets
(Millions of US $)
2023 $45
2022 $52
2021 $94
2020 $143
2019 $168
2018 $215
2017 $129
2016 $42
2015 $48
2014 $57
2013 $5
2012 $18
2011 $29
GlycoMimetics Quarterly Total Assets
(Millions of US $)
2023-12-31 $45
2023-09-30 $53
2023-06-30 $62
2023-03-31 $69
2022-12-31 $52
2022-09-30 $56
2022-06-30 $65
2022-03-31 $81
2021-12-31 $94
2021-09-30 $108
2021-06-30 $124
2021-03-31 $138
2020-12-31 $143
2020-09-30 $150
2020-06-30 $158
2020-03-31 $162
2019-12-31 $168
2019-09-30 $180
2019-06-30 $192
2019-03-31 $204
2018-12-31 $215
2018-09-30 $225
2018-06-30 $236
2018-03-31 $247
2017-12-31 $129
2017-09-30 $116
2017-06-30 $122
2017-03-31 $37
2016-12-31 $42
2016-09-30 $48
2016-06-30 $56
2016-03-31 $41
2015-12-31 $48
2015-09-30 $56
2015-06-30 $62
2015-03-31 $48
2014-12-31 $57
2014-09-30 $62
2014-06-30 $68
2014-03-31 $58
2013-12-31 $5
2013-09-30 $10
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2011-12-31 $29
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.124B $0.000B
GlycoMimetics, Inc. is a biotechnology company. The company focused on the discovery and development of novel glycomimetic drugs to address diseases in which carbohydrate biology plays a key role. It product pipeline includes GMI-170, GMI-1271, E-selectin and CXCR4 antagonist, GMI-1051 and GMI-1070 at different clinical phases. GlycoMimetics, Inc. is based in Gaithersburg, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $67.003B 27.54
Chugai Pharmaceutical (CHGCY) Japan $52.278B 22.70
Takeda Pharmaceutical (TAK) Japan $41.902B 6.79
Merck (MKGAF) Germany $20.162B 19.02
Astellas Pharma (ALPMY) Japan $17.192B 24.36
Shionogi (SGIOY) Japan $14.152B 12.24
Sandoz Group AG (SDZNY) Switzerland $13.930B 0.00
Neurocrine Biosciences (NBIX) United States $13.135B 54.54
United Therapeutics (UTHR) United States $11.197B 11.99
Catalent (CTLT) United States $10.040B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.926B 7.02
Ionis Pharmaceuticals (IONS) United States $5.929B 0.00
Revolution Medicines (RVMD) United States $5.751B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.231B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.219B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.991B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.767B 0.00
Indivior (INDV) United States $2.554B 11.87
Evotec AG (EVO) Germany $2.505B 0.00
Summit Therapeutics (SMMT) United States $2.456B 0.00
Corcept Therapeutics (CORT) United States $2.389B 24.16
Dyne Therapeutics (DYN) United States $2.056B 0.00
PTC Therapeutics (PTCT) United States $1.940B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.804B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.786B 18.45
NewAmsterdam Pharma (NAMS) Netherlands $1.779B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.725B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.664B 9.85
Taro Pharmaceutical Industries (TARO) Israel $1.588B 27.80
Avadel Pharmaceuticals (AVDL) Ireland $1.570B 0.00
Ardelyx (ARDX) United States $1.508B 0.00
4D Molecular Therapeutics (FDMT) United States $1.292B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.240B 11.65
Pacira BioSciences (PCRX) United States $1.221B 12.15
Soleno Therapeutics (SLNO) United States $1.217B 0.00
Collegium Pharmaceutical (COLL) United States $1.139B 7.01
Xencor (XNCR) United States $1.123B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.060B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.913B 0.00
Cronos Group (CRON) Canada $0.905B 0.00
Cassava Sciences (SAVA) United States $0.849B 0.00
USANA Health Sciences (USNA) United States $0.849B 13.37
ARS Pharmaceuticals (SPRY) United States $0.817B 0.00
Enliven Therapeutics (ELVN) United States $0.809B 0.00
Sage Therapeutics (SAGE) United States $0.801B 0.00
Relay Therapeutics (RLAY) United States $0.782B 0.00
Ocular Therapeutix (OCUL) United States $0.776B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.722B 0.00
Silence Therapeutics (SLN) United Kingdom $0.678B 0.00
Savara (SVRA) United States $0.664B 0.00
Siga Technologies (SIGA) United States $0.593B 8.78
Lyell Immunopharma (LYEL) United States $0.567B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.557B 0.00
Verve Therapeutics (VERV) United States $0.555B 0.00
OmniAb (OABI) United States $0.547B 0.00
Korro Bio (KRRO) United States $0.535B 0.00
Exscientia (EXAI) United Kingdom $0.513B 0.00
Altimmune (ALT) United States $0.490B 0.00
KalVista Pharmaceuticals (KALV) United States $0.488B 0.00
ProKidney (PROK) United States $0.468B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.454B 0.00
Larimar Therapeutics (LRMR) United States $0.417B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.412B 0.00
Lexeo Therapeutics (LXEO) United States $0.397B 0.00
Heron Therapeutics (HRTX) United States $0.397B 0.00
Tourmaline Bio (TRML) United States $0.396B 0.00
Organogenesis (ORGO) United States $0.383B 72.50
Harrow (HROW) United States $0.370B 0.00
Esperion Therapeutics (ESPR) United States $0.369B 0.00
Nature's Sunshine Products (NATR) United States $0.363B 20.31
Bioventus (BVS) United States $0.355B 0.00
Fractyl Health (GUTS) United States $0.314B 0.00
Lyra Therapeutics (LYRA) United States $0.310B 0.00
Aquestive Therapeutics (AQST) United States $0.301B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.296B 0.00
Akebia Therapeutics (AKBA) United States $0.285B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.282B 0.00
ESSA Pharma (EPIX) Canada $0.280B 0.00
Black Diamond Therapeutics (BDTX) United States $0.272B 0.00
Metagenomi (MGX) United States $0.258B 0.00
Nanobiotix S.A (NBTX) France $0.255B 0.00
Adherex Technologies (FENC) United States $0.253B 0.00
Xeris Biopharma Holdings (XERS) United States $0.244B 0.00
Pyxis Oncology (PYXS) United States $0.242B 0.00
Telomir Pharmaceuticals (TELO) United States $0.236B 0.00
Nektar Therapeutics (NKTR) United States $0.228B 0.00
Aldeyra Therapeutics (ALDX) United States $0.227B 0.00
Conduit Pharmaceuticals (CDT) United States $0.227B 0.00
Foghorn Therapeutics (FHTX) United States $0.226B 0.00
Avita Medical (RCEL) United States $0.222B 0.00
Acrivon Therapeutics (ACRV) United States $0.213B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Prelude Therapeutics (PRLD) United States $0.204B 0.00
Century Therapeutics (IPSC) United States $0.200B 0.00
Zevra Therapeutics (ZVRA) United States $0.196B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.189B 0.00
Achieve Life Sciences (ACHV) Canada $0.154B 0.00
CytoDyn (CYDY) United States $0.154B 0.00
Incannex Healthcare (IXHL) Australia $0.151B 0.00
MediWound (MDWD) Israel $0.150B 0.00
Regulus Therapeutics (RGLS) United States $0.139B 0.00
Elite Pharmaceuticals (ELTP) United States $0.139B 13.00
Karyopharm Therapeutics (KPTI) United States $0.135B 0.00
VAXART, INC (VXRT) United States $0.134B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.127B 2.67
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Relmada Therapeutics (RLMD) United States $0.121B 0.00
Citius Pharmaceuticals (CTXR) United States $0.120B 0.00
FibroGen (FGEN) United States $0.114B 0.00
Inotiv (NOTV) United States $0.111B 0.00
Eliem Therapeutics (ELYM) United States $0.107B 0.00
OptiNose (OPTN) United States $0.101B 0.00
ProPhase Labs (PRPH) United States $0.095B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
Aclaris Therapeutics (ACRS) United States $0.088B 0.00
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.076B 0.00
Assertio Holdings (ASRT) United States $0.073B 5.95
Journey Medical (DERM) United States $0.069B 0.00
Tempest Therapeutics (TPST) United States $0.069B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Mural Oncology (MURA) $0.060B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.054B 0.81
BioLineRx (BLRX) Israel $0.052B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Jaguar Animal Health (JAGX) United States $0.043B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Unicycive Therapeutics (UNCY) United States $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
JanOne (JAN) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.034B 0.00
VYNE Therapeutics (VYNE) United States $0.032B 0.00
Nutriband (NTRB) United States $0.031B 0.00
Protara Therapeutics (TARA) United States $0.030B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Surrozen (SRZN) United States $0.030B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Lipocine (LPCN) United States $0.028B 0.00
DURECT (DRRX) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.67
CERo Therapeutics Holdings (CERO) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.09
TherapeuticsMD (TXMD) United States $0.021B 0.00
Addex Therapeutics (ADXN) Switzerland $0.021B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Aptorum Group (APM) United Kingdom $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Alaunos Therapeutics (TCRT) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Inhibikase Therapeutics (IKT) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.21
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.11